<DOC>
	<DOCNO>NCT01714297</DOCNO>
	<brief_summary>The purpose study determine difference clinical event , i.e bleed associate morbidity , thromboprophylaxis LMWH ( Low Molecular Weight Heparin ) initiate surgery .</brief_summary>
	<brief_title>Preoperative Versus Postoperative Start With Thromboprophylaxis THA ( Total Hip Arthroplasty )</brief_title>
	<detailed_description />
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>patient 50 year old undergoing cement total hip arthroplasty primary osteoarthritis allergy LowMolecularWeight Heparin bleed disorder renal failure hepatic disease active treatment malignancy history deep venous thrombosis pulmonary embolism major operation , trauma , stroke cardiac infarction last 3 month surgery .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>cement total hip arthroplasty</keyword>
	<keyword>blood loss</keyword>
	<keyword>wound discharge</keyword>
	<keyword>thromboprophylaxis</keyword>
	<keyword>biomarkers</keyword>
</DOC>